A new class of drug slows growth of castration-resistant prostate cancer cells
2/01/2016
Study shows reduced proliferation of aggressive prostate cancer cells after treatment with a novel compound targeting the sphingolipid pathway.
New biomarker to assess stem cells developed
2/01/2016
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs).
Oncologists issue guidance for allocating scarce chemotherapy drugs
2/01/2016
Claiming that clinicians lack formal and concrete allocation guidance when faced with a critical drug shortage, experts in pediatric oncology and bioethics have issued a framework to avoid waste and...
New insights into DNA repair could improve drugs that block cancer cell growth
2/01/2016
By clarifying how some DNA repair mechanisms work, a new study opens the way to better understanding and thus improving the action of drugs that prevent cancer cell proliferation.
Acai Berries: Health Benefits, Nutritional Information
2/01/2016
Learn all about the potential health benefits of acai berries, a fruit rich in antioxidants whose taste has been described as a blend of chocolate and berries.
High fiber intake when young may lower women's breast cancer risk
2/01/2016
Researchers found that women who ate foods high in fiber during adolescence and young adulthood were up to 24% less likely to develop breast cancer.
Miniature microscope will ID cancer cells in real-time
1/31/2016
A new microscope the size of a pen will allow doctors and dentists to check for cancerous cells without surgery and without an excruciating wait for results.
Miniature microscope will ID cancer cells in real-time
1/31/2016
A new microscope the size of a pen will allow doctors and dentists to check for cancerous cells without surgery and without an excruciating wait for results.
Proton beam therapy - a more precise form of radiotherapy - to treat the childhood brain cancer medulloblastoma appears to be as safe as conventional radiotherapy with similar survival rates...
FDA approves first drug to show survival benefit in liposarcoma
1/29/2016
The U.S. Food and Drug Administration has approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be...